全文获取类型
收费全文 | 2291篇 |
免费 | 121篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 172篇 |
妇产科学 | 26篇 |
基础医学 | 292篇 |
口腔科学 | 58篇 |
临床医学 | 297篇 |
内科学 | 644篇 |
皮肤病学 | 75篇 |
神经病学 | 60篇 |
特种医学 | 391篇 |
外科学 | 100篇 |
综合类 | 49篇 |
预防医学 | 98篇 |
眼科学 | 20篇 |
药学 | 92篇 |
2篇 | |
肿瘤学 | 111篇 |
出版年
2023年 | 5篇 |
2022年 | 8篇 |
2021年 | 12篇 |
2020年 | 14篇 |
2019年 | 17篇 |
2018年 | 35篇 |
2017年 | 22篇 |
2016年 | 24篇 |
2015年 | 39篇 |
2014年 | 53篇 |
2013年 | 61篇 |
2012年 | 50篇 |
2011年 | 64篇 |
2010年 | 93篇 |
2009年 | 89篇 |
2008年 | 71篇 |
2007年 | 119篇 |
2006年 | 72篇 |
2005年 | 76篇 |
2004年 | 50篇 |
2003年 | 31篇 |
2002年 | 44篇 |
2001年 | 51篇 |
2000年 | 45篇 |
1999年 | 40篇 |
1998年 | 130篇 |
1997年 | 158篇 |
1996年 | 133篇 |
1995年 | 111篇 |
1994年 | 114篇 |
1993年 | 97篇 |
1992年 | 30篇 |
1991年 | 39篇 |
1990年 | 40篇 |
1989年 | 58篇 |
1988年 | 52篇 |
1987年 | 45篇 |
1986年 | 50篇 |
1985年 | 48篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 27篇 |
1981年 | 30篇 |
1980年 | 25篇 |
1979年 | 4篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 25篇 |
1975年 | 14篇 |
1966年 | 1篇 |
排序方式: 共有2488条查询结果,搜索用时 15 毫秒
991.
Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions 总被引:4,自引:1,他引:4
Type VI collagen is a subendothelial constituent that binds von Willebrand factor (vWF) and platelets. The interaction of platelets with type VI collagen and the roles of platelet glycoprotein (GP) receptors and vWF were studied under flow conditions using epi- fluorescent videomicroscopy coupled with digital image processing. We found that surface coverage was less than 6% on collagen VI at a relatively high-wall shear rate (1,000 s-1) and was approximately 60% at a low-wall shear rate (100 s-1). The molecular mechanisms involved in low-shear platelet binding were studied using monoclonal antibodies to platelet GPIb and GPIIb-IIIa, and polymeric aurin tricarboxylic acid. Anti-GPIIb-IIIa was the most effective in eliminating adhesion (surface coverage, 0.8%), followed by anti-GPIb (4.3%), and ATA (12.6%). Experiments with von Willebrand disease blood indicate that vWF is involved in platelet adhesion to collagen VI at 100 s-1. In the absence of vWF, there may be direct binding of platelet GPIIb-IIIa complexes to collagen VI. Adhesion and aggregation on collagen VI are different in shear rate dependence from collagen I. Our results suggest a possible role for collagen VI and vWF in platelet adhesion and aggregation in vascular regions with low shear rates. 相似文献
992.
Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia 总被引:12,自引:2,他引:12
The p16 gene, also referred to as MTS1, INK4, CDK4I, or CDKN2, at chromosome 9p21 has recently been described as a tumor suppressor that may be involved in a wide range of tumors. We have used a semiquantitative multiplex polymerase chain reaction assay to search for deletions of the p16 gene in 34 patients with chronic myeloid leukemia in blast crisis (CML BC), 19 patients with acute lymphoblastic leukemia (ALL), and 25 patients with acute myeloid leukemia (AML). Homozygous deletions of p16 exons were found in 5 of 10 (50%) patients with CML in lymphoid BC and in 5 (26%) ALL patients, but in only 1 (2%) case with AML. No deletions were found in CML BC of nonlymphoid phenotype. Comparison of chronic phase DNA or remission DNA with acute leukemia DNA in 5 individuals showed that the p16 deletions were acquired and not inherited, directly implicating these lesions in the pathogenesis of the disease. We conclude that functional elimination of the p16 gene, or a closely mapping gene, is involved in a significant number of patients with CML in lymphoid transformation. 相似文献
993.
O Chassany D Elkharrat JF Bergmann JM Segrestaa 《La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne》1995,16(12)
Gastroesophageal reflux is a common disease. Its chronic course, even if mild, is sometimes complicated by erosive oesophagitis. Drug therapy acts against gastric acidity and motility disorders. Treatment of gastroesophageal reflux disease has three aims: improvement of symptoms and quality of life, healing erosive lesions and prevention of symptomatic and endoscopie relapses. Non-drug measures are always useful, even if their efficacy is not well established. Initial therapy of a symptomatic reflux or mild oesophagitis is most of the time effective (antacids, prokinetics, H2 receptor antagonists). Proton-pump inhibitors are also effective in healing and preventing severe oesophagitis. Questions about long-term treatment adverse events with powerful acid inhibitors, such as hypergastrinemia and the risk of gastric carcinoid tumours seem to be resolved. Studies are requested to define the optimal long-term maintenance treatment with cisapride, H2 receptor antagonists or proton-pump inhibitors at low doses in prevention of symptomatic and mild oesophagitis relapses. 相似文献
994.
Rabinowe SN; Neuberg D; Bierman PJ; Vose JM; Nemunaitis J; Singer JW; Freedman AS; Mauch P; Demetri G; Onetto N 《Blood》1993,81(7):1903-1908
One hundred and twenty-eight patients with non-Hodgkin's lymphoma (NHL), Hodgkin's disease (HD), and acute lymphoblastic leukemia (ALL) previously reported from a phase III trial of rhGM-CSF or placebo following autologous bone marrow transplantation (ABMT) were investigated for the development of late toxicities. Median follow-up is 36 months. No apparent long-term deleterious effects on BM function were observed. Moreover, disease-free survival and overall survival were similar for patients on both treatment arms, arguing for the long- term safety of recombinant human granulocyte macrophage-colony- stimulating factor (rhGM-CSF). The only factors predictive for both a high risk of relapse over time and mortality were having the diagnosis of ALL and/or undergoing ABMT in resistant relapse. We attempted to identify clinical variables before BM harvest, at the time of marrow infusion, or events within the first 100 days posttransplant, which might predict speed of neutrophil recovery in the setting of placebo or rhGM-CSF administration after ABMT. Only previous exposure to agents that deplete stem cells led to a significant delay in neutrophil recovery, suggesting their avoidance in patients who may undergo ABMT. Nevertheless, even those patients benefited from rhGM-CSF. For all patients, rhGM-CSF and agents that deplete stem cells were the strongest independent predictors for neutrophil engraftment. With the increasing use of newer hematopoietic growth factors both alone and in combination, long-term follow-up is essential to confirm the same safety that we report with rhGM-CSF. 相似文献
995.
Delva L; Cornic M; Balitrand N; Guidez F; Miclea JM; Delmer A; Teillet F; Fenaux P; Castaigne S; Degos L 《Blood》1993,82(7):2175-2181
All-trans retinoic acid (ATRA) induces leukemic cell differentiation and complete remission (CR) in a high proportion of patients with acute promyelocytic leukemia (AML3 subtype). However, relapses occur when ATRA is prescribed as maintenance therapy, and resistance to a second ATRA-induction therapy is frequently observed. An induced hypercatabolism of ATRA has been suggested as a possible mechanism leading to reduced ATRA sensitivity and resistance. CRABPII, an RA cytoplasmic binding protein linked to RA's metabolization pathway, is induced by ATRA in different cell systems. To investigate whether specific features of the AML3 cells at relapse could explain the in vivo resistance observed, we studied the CRABP levels and in vitro sensitivity to ATRA of AML3 cells before and at relapse from ATRA. Relapse-AML3 cells (n = 12) showed reduced differentiation induction when compared with "virgin"-AML3 cells (n = 31; P < .05). Dose-response studies were performed in 2 cases at relapse and showed decreased sensitivity to low ATRA concentrations. CRABPII levels and in vitro differentiation characteristics of AML3 cells before and at relapse from ATRA therapy were studied concomittantly in 4 patients. High levels of CRABPII (median, 20 fmol/mg of protein) were detected in the cells of the 4 patients at relapse but were not detected before ATRA therapy. Three of these patients showed a decrease in differentiation induction of their leukemic cells, and a failure to achieve CR with a second induction therapy of ATRA 45 mg/m2/day was noted in all patients treated (n = 3). Results from this study provide evidence to support the hypothesis of induced-ATRA metabolism as one of the major mechanisms responsible for ATRA resistance. Monitoring CRABPII levels after ATRA withdrawal may help to determine when to administer ATRA in the maintenance or relapse therapy of AML3 patients. 相似文献
996.
Suppression of B-cell development as a result of selective expansion of donor T cells during the minor H antigen graft-versus-host reaction 总被引:1,自引:2,他引:1
A murine model of bone marrow (BM) transplantation in which donor (B10.D2) and recipient (BALB/c) mice were major histocompatibility complex (MHC) (H-2d) and Mls-1 identical, but incompatible at multiple non-MHC minor histocompatibility (H) antigens, and at Mls-2,3 was used to examine regeneration of B-cell development during the minor H antigen graft-versus-host reaction (GVHR). Mice that received T-cell- depleted allogeneic BM regained significant pre-B cells (sIg- 14.8+) in their BM. Mice undergoing GVHR after transplantation with allogeneic BM + T cells had less than 2% pre-B cells in their BM at day 7 and only 12% to 14% pre-B cells at days 21 and 28 compared with greater than 20% pre-B cells in the allogeneic controls. After partial recovery, the pre- B cells in the BM of GVH mice again decreased to less than 3% by day 42. This abnormal pattern of pre-B cell development in mice undergoing GVHR was associated with a reduced response to interleukin-7 (IL-7) in vitro. The delay in B-lineage cell reconstitution in mice with GVHR correlated with the expansion of donor V beta 3+ T cells in both the spleen and BM. BM T cells from mice with GVHR as well as isolated V beta 3+ T cells inhibited IL-7 colony-forming units from normal BM in co-culture assays. This inhibition could be reversed with anti- interferon gamma (IFN gamma) antibody. These data suggest that the delay in appearance and the reduction in proportion and number of pre-B cells observed early during the GVH reaction in this model is caused, in part, by the inhibitory actions of IFN gamma derived from donor V beta 3+ T cells on B-lineage cell development. 相似文献
997.
Stage Ⅱ surgical resection of hepatocellular carcinoma after TAE: a report of 38 cases 总被引:5,自引:0,他引:5
StageⅡsurgicalresectionofhepatocelularcarcinomaafterTAE:areportof38casesWANGJianHua,LINGui△,YANZhiPing,WANGXiaoLin,CHENGJ... 相似文献
998.
999.
Martens FM; van der Vleuten CP; Grol RP; op 't Root JM; Crebolder HF; Rethans JJ 《Family practice》1997,14(2):153-159
OBJECTIVES: The main aim of this study was to reach consensus between
students, faculty and general practice teachers on the educational
objectives and requirements of the clerkship in general practice. METHOD:
The consensus procedure consisted of four steps and all active general
practice teachers (n = 116) were asked to participate in the study.
RESULTS: We identified 189 educational objectives: 127 complaints
(problems, symptoms, syndromes), 29 clinical skills and 37 objectives
concerning the theoretical dimensions of general practice. Educational
requirements crystallized to 16 essential preconditions of a teaching
practice and 35 didactic activities to be performed by the general practice
teachers. CONCLUSIONS: These consensus results will be used to structure
the medical curriculum and as guidelines for the educational process during
the clerkship.
相似文献
1000.
2-(Allylthio)pyrazine (2-AP), synthesized for its possible use as a
hepatoprotective agent, has been found to selectively inhibit rat hepatic
cytochrome P450 2E1 (Kim et al., Biochem. Pharmacol., 53, 261- 269, 1997),
while it enhances the activities of phase II detoxification enzymes such as
glutathione S-transferase and epoxide hydrolase. As part of a program in
evaluating the chemopreventive potential of 2-AP, we have determined its
effects on hepatotoxicity, mutagenicity and tumorigenicity of vinyl
carbamate (VC), a prototypic hepatocarcinogen preferentially activated by
P450 2E1 to the ultimate carcinogenic metabolite vinyl carbamate epoxide
(VCO), which undergoes detoxification by glutathione conjugation and
oxirane hydrolysis. Administration of 2-AP (100 mg/kg body wt) to male
Sprague-Dawley rats by gavage, 2 days, 1 day and 4 h prior to VC or VCO,
markedly ameliorated the hepatotoxicity of these compounds as determined by
decreased serum aspartate aminotransferase and alanine aminotransferase
activities. Furthermore, 2-AP pre-treatment significantly suppressed the
VC-induced hepatocarcinogenesis in infant male B6C3F1 mice. In a separate
experiment, the multiplicities of skin tumors formed in female ICR mice
treated with 5.8 micromol of VC or VCO were inhibited 58 and 70%,
respectively, by pre-treatment with 2-AP by oral administration. The
mutational spectrum of ras-oncogene in papillomas was not altered by 2-AP
pre-treatment. 2-AP also inhibited the mutagenicity of VC in the
Salmonella-microsome assay. Taken together, these findings suggest that
2-AP is a potential chemopreventive agent.
相似文献